Skip to main content
. Author manuscript; available in PMC: 2020 Oct 13.
Published in final edited form as: Eur J Intern Med. 2020 Jun 30;80:45–53. doi: 10.1016/j.ejim.2020.04.056

Table 2A.

Example Quality Improvement Initiatives for Diagnostic Evaluation of AKI

Recognition Action Results
High readmission rates for persistent AKI after cardiac angiography were not properly screened for AKI. • Assessment of risk for AKI pre angiography and increasing follow-up serum creatinine assessment post-angiography in those at high risk to improve initial detection and determine reversibility • Documentation of risk assessment for AKI pre angiography
• Improved proportion of patients with AKI that have a follow-up serum creatinine post angio
• Reduced rehospitalizations for severe/complications of AKI
High incidence of progressive AKI following gynecologic surgery • Assessment of urine volume following surgery, or screening for nephrotoxin use (e.g., NSAIDs)
• Protocol for imaging with the detection of decreased urine volume or elevation of serum creatinine
• Improved imaging frequency
Documentation of serial assessment of urine volume after surgery
• Improved frequency of evaluation for ureteral injury
• Decreased AKI frequency? /reduce nephrotoxin exposure?
General Hospital Population with persistent AKI (any stage) • Determining populations and setting with increased AKI frequency
• Assessment of risk factors for AKI in the specific population
• Protocol for urinalysis, follow-up serum creatinine, nephrotoxin evaluation, ultrasound in patients with risk factors
• Documentation decreasing rates of AKI frequency in specific populations and settings
• Increased detection of potential nephrotoxin exposures
• Reduced severity/duration of AKI